Literature DB >> 23411466

Low GFI1 expression in white blood cells of CP-CML patients at diagnosis is strongly associated with subsequent blastic transformation.

C H Kok, D B Watkins, T Leclercq, R J D'Andrea, T P Hughes, D L White.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23411466     DOI： 10.1038/leu.2013.47

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  7 in total

1.  Elevated PTPN2 expression is associated with inferior molecular response in de-novo chronic myeloid leukaemia patients.

Authors:  C H Kok; T Leclercq; D B Watkins; V Saunders; J Wang; T P Hughes; D L White
Journal:  Leukemia       Date:  2013-11-06       Impact factor: 11.528

Review 2.  Selecting the best frontline treatment in chronic myeloid leukemia.

Authors:  Musa Yilmaz; Yasmin Abaza; Elias Jabbour
Journal:  Curr Hematol Malig Rep       Date:  2015-06       Impact factor: 3.952

3.  Sustained inhibition of STAT5, but not JAK2, is essential for TKI-induced cell death in chronic myeloid leukemia.

Authors:  L Schafranek; E Nievergall; J A Powell; D K Hiwase; T Leclercq; T P Hughes; D L White
Journal:  Leukemia       Date:  2014-05-12       Impact factor: 11.528

4.  GFI1 as a novel prognostic and therapeutic factor for AML/MDS.

Authors:  J M Hönes; L Botezatu; A Helness; C Vadnais; L Vassen; F Robert; S M Hergenhan; A Thivakaran; J Schütte; Y S Al-Matary; R F Lams; J Fraszscak; H Makishima; T Radivoyevitch; B Przychodzen; S V da Conceição Castro; A Görgens; B Giebel; L Klein-Hitpass; K Lennartz; M Heuser; C Thiede; G Ehninger; U Dührsen; J P Maciejewski; T Möröy; C Khandanpour
Journal:  Leukemia       Date:  2016-02-05       Impact factor: 11.528

5.  TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets.

Authors:  David T Yeung; Michael P Osborn; Deborah L White; Susan Branford; Jodi Braley; Alan Herschtal; Michael Kornhauser; Samar Issa; Devendra K Hiwase; Mark Hertzberg; Anthony P Schwarer; Robin Filshie; Christopher K Arthur; Yiu Lam Kwan; Judith Trotman; Cecily J Forsyth; John Taper; David M Ross; Jennifer Beresford; Constantine Tam; Anthony K Mills; Andrew P Grigg; Timothy P Hughes
Journal:  Blood       Date:  2014-12-17       Impact factor: 22.113

6.  Enforced GFI1 expression impedes human and murine leukemic cell growth.

Authors:  Judith M Hönes; Aniththa Thivakaran; Lacramioara Botezatu; Pradeep Patnana; Symone Vitoriano da Conceição Castro; Yahya S Al-Matary; Judith Schütte; Karen B I Fischer; Lothar Vassen; André Görgens; Ulrich Dührsen; Bernd Giebel; Cyrus Khandanpour
Journal:  Sci Rep       Date:  2017-11-16       Impact factor: 4.379

7.  Growth factor independence 1b (gfi1b) is important for the maturation of erythroid cells and the regulation of embryonic globin expression.

Authors:  Lothar Vassen; Hugues Beauchemin; Wafaa Lemsaddek; Joseph Krongold; Marie Trudel; Tarik Möröy
Journal:  PLoS One       Date:  2014-05-06       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.